AgeX Therapeutics

AGE AMEX
2.720
-0.090
-3.20%
Opening 10:18 07/22 EDT
Open
2.900
Prev Close
2.810
High
2.900
Low
2.720
Volume
2.31K
Avg Vol (3M)
95.19K
52 Week High
5.95
52 Week Low
1.130
% Turnover
0.01%
Market Cap
102.35M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers AgeX Therapeutics AGE stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

AgeX Therapeutics Inc. is a biotechnology company. The Company is focused on the development and commercialization of therapeutics targeting human aging. Its induced Tissue Regeneration (iTR) technology is based telomerase-mediated cellular immortality and regenerative biology. Its pipeline includes two cell-based, two drug-based therapeutic products, online database products and research products. The Company’s AGEX-BAT1 is its cell therapy product candidate that is being developed for the treatment of certain age-related metabolic disorders, such as Type II (adult-onset) diabetes. AGEX-VASC1 is its cell-based therapy that is designed to restore vascular support in aged ischemic tissues such as the aging heart. AGEX-iTR1547 is its drug-based formulation developed to restore regenerative potential in an array of aged tissues afflicted with degenerative disease using its proprietary iTR technology. Renelon is its iTR product candidate designed to promote scar less tissue repair.
MORE >

Recently

Name
Price
%Change